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Structural-functional relationships in type I mesangiocapillary glomer-
ulonephritis. We quantitated glomerular and cortical interstitial struc-
tures in nine type I mesangiocapillary glomerulonephritis (MCGN)
patients aged 6 to 20 years whose creatinine clearance (Car) was 10 to
129 ml/minJl.73 rn,2 as compared to age-matched normal controls.
Mean glomerular volume and mesangial volume fraction [Vv(mes/
glom)] were increased and the percentage of the capillary endothelial
circumference which was defined as filtration surface was decreased in
type I MCGN patients. Vv(mes/glom) was inversely related to filtration
surface area per glomerulus (r =
—0.73, P < 0.05) and directly to
volume density of cortical interstitium [Vv(int/cortex)] (r = +0.90; P <
0.01). Vv(mes/glom) (r = —0.87; P < 0.01), filtration surface area per
glomerulus (r = +0.83; P < 0.01) and Vv(int/cortex) (r = —0.86; P <
0.01) were correlated with Car. Thus, in type I MCGN, measures both
of glomerular and of cortical interstitial structure are highly correlated
with glomerular function.
Type I mesangiocapillary glomerulonephritis (MCGN) is a
primary glomerular disease with distinct morphologic patterns
and hypocomplementemia. Structurally, there is marked me-
sangial expansion, with a tendency to glomerular lobulation.
Mesangial interposition between the endothelial layer and the
glomerular basement membrane leads to thickening of capillary
walls and the characteristic "double contour" or tramtrack
appearance. Many authors have reported that the long-term
prognosis of type I MCGN is generally unfavorable, though in
a given case it may be variable [1, 2]. Recently Schmitt et al [3]
reported that within five years after biopsy, 49% of the patients
had died or needed dialysis treatment; after 10 years this
increased to 64%. Clinically, nephrotic syndrome, hyperten-
sion, and elevated serum creatinine values at the time of biopsy
are of prognostic significance. Structurally, lobular glomerulo-
nephritis, crescent formation and tubulointerstitial changes
have been related to the prognosis for this disease [4, 5].
Further, it has been argued that interstitial but not glomerular
structural changes are related to functional alterations in
MCGN [6, 7]. However, careful quantitation of both glomerular
and interstitial structure and relating of these measures to renal
function have not been done for MCGN as has been reported
for diabetes [8]. Thus, we analyzed the renal biopsies of nine
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patients with type I MCGN by morphometry, and the findings
were compared to age-matched normal kidney donors.
Methods
Patients
Nine (5 male) patients with type I MCGN were evaluated
(Table 1). The diagnosis of type I MCGN was made using the
following criteria: (1) light microscopy, diffuse mesangial pro-
liferation and thickening of glomerular capillary walls with
double contours or tramtrack appearance; (2) electron micros-
copy, subendothelial deposits and mesangial interposition, oc-
casional subepithelial deposits; and (3) immunofluorescence
microscopy, predominant C3 and properdin in a peripheral
lobular pattern, sometimes with IgG.
At the time of renal biopsy the nine patients were between 6
and 20 years of age [11.1 4.6 years ( SD)]. Patients
numbered 1, 8 and 9 were found to have abnormal urine
analysis on routine examination; patient #7 was found to have
an abnormal urine analysis after complaints of abdominal pain;
the remaining four patients presented with edema. Before renal
biopsy each patient had one or two 24-hour urine collections for
creatinine clearance (Car) and urinary protein excretion using
standard laboratory procedures. Blood pressure data were
based on repeated determinations available over at least several
days of the biopsy admission, and hypertension was defined by
the criteria of the Joint National Committee on the Detection,
Evaluation and Treatment of High Blood Pressure [9] and the
Task Force of Blood Pressure Control in Children [10]. A
percutaneous renal biopsy was performed for clinical indica-
tions after obtaining informed consent from each patient or the
responsible parent. Biopsy was performed using the Vim-
Silverman needle.
At the time of biopsy three patients had hypertension, four
impaired renal function and six (all but patients number I and 2)
had hypocomplementemia (Table 1). However, none of the five
patients whose Cr exceeded 80 ml/min/l .73 m2 had hyperten-
sion (Table 1). Renal biopsy was performed 16 days to 16
months (average 4.5 months) from the first detection of the
disease; six cases (67%) were biopsied within the first two
months of disease detection.
Control biopsies were obtained at the time of donation for
kidney transplantation from five (4 male, 1 female) normal aged
matched people ages 6 to 20 years (13.6 6.6 years).
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Table 1. Characteristics of patients with type I MCGN
Case no.
Age at
biopy
years Sex
C at
biopsy
mi/mini
1.73 m2
Urinary
protein
excretion
gidaylm2 Hypertension
Time of
follow-up
since biopsy
months
Current cimica! status
C.
mi/mini
1.73 m2
Urinary
protein
excretior
gidayim
1
2
3
4
5
6
7
8
9
20
7
9
8
9
11
14
6
16
M
F
F
F
M
F
M
M
M
10
23
34
63
82
102
119
128
129
3.37
2.50
2.08
2.83
1.84
0.15
0.47
2.82
2.32
Yes
No
Yes
Yes
No
No
No
No
No
64
20
36
5
5
10
75
9
3
CRF
88
32
75
73
136
137
143
154
Tx
ND
1.00
0.07
1.63
0.37
0.59
0.82
1.03
N
Mean
SD
9
11.1
4.6
9
76.7
46.3
9
2.04
1.08
9
25.2
27.2
8
104.8
43.7
7
0.79
0.51
Abbreviations are: Car, creatinine clearance; CRF, chronic renal failure; Tx, renal transplantation; ND, not done.
Tissue processing
A portion of the tissue was fixed in Zenker's solution,
embedded in paraffin, and sections stained with periodic acid
Schiff (PAS) were used for interstitial and glomerular volume
measurements.
Tissue for electron microscopy was fixed, embedded and
sectioned as described elsewhere in detail [8]. Randomly se-
lected centermost, nonscierosed glomeruli at least one tubular
diameter from the edge of the tissue were thin sectioned [8].
Sclerotic glomeruli were excluded. At least three glomeruli for
each subject were photographed at magnifications of approxi-
mately x3,900, xll,000 and x22,000. The x3,900 micrographs
were placed together to form a montage of the entire glomerular
cross section [11]. A calibration grid was photographed with
each montage to determine final magnification [8].
Morphometric analysis
Mean glomerular volume (GV) was determined on the light
microscopic sections at an approximate magnification of x 200
using the method of Hirose et al [12]. Only sections at least 150
m apart were used in order to minimize remeasuring the same
glomerulus. All biopsies but two had at least 30 giomeruli for
evaluation. Case #3 had 14 and case #8 had 15 glomeruli. The
number of glomeruli averaged 56 44 (range 14 to 169).
Volume density of mesangium [Vv(mes/glom)] was measured
on the montage taken at x3900. A double lattice square grid
with equally spaced coarse points 6 cm apart, and equally
spaced fine points 3 cm apart was used so that each coarse point
defined four fine points. Fine points were counted to determine
the number of points falling on mesangium (PM), whereas
coarse points were counted to determine points falling on the
glomerular area (PG). Since each coarse point defined four fine
points, then
PM
________________________________________
Vv(meslglom) = (m /pm ) [8, 13]r3 X 's
Then on photographs of an approximate magnification of
x 11,000 fine points were counted to determine the number of
points falling on the mesangial cell (PMC) and matrix (PMM)
respectively. And
PMC 3
VV(mes ceIl/glom) = VV(mes/glom) X . (sm /pm )
rf + PMM
PMM
VV(mes matrix/glom) = V(mes/gIom) x (sm3/j.m)MC + PMM
Mesangial volume per glomerulus was calculated by multi
plying average glomerular volume times Vv(mes/glom) [141.
Surface density of the peripheral glomerular basement mem
brane (PGBM) [SV(pGBglQm)l and the mesangial capillar)
lumenal surface [Sv(mes lumen/glom)] were determined b)
counting interceptions (I) between the interface of interest an
the lines on the grid [15, 16]. Then,
2x1
Sy = 2 X 1L =
60000 (m3im3)
XPG
magnification
Where 'L = number of intercepts divided by the length of th
grid lines overlying the reference space, the glomerular tuft.
The PGBM was defined as the trilaminar surface of th
epithelial cell, GBM and endothelial cell of the periphera
capillary wall, as previously described [14]. The mesangia
capillary lumenal surface represents the interface of endothelia
cells with mesangial matrix or cellular components.
Together PGBM and mesangial capillary lumenal surfac
represent the endothelial circumference of the glomerular cap
illary. Thus % of endothelial circumference occupied by PGBIv
can be determined.
PGBM% of endothelial circumference
Sv(PGBM/glom)
x 100
Sv(pGBM/glom) + Sv(mes lumen/glom)
And PGBM surface per glomerulus was then calculated b
multiplying average glomerular volume times SV(POBM/gIQm).
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Table 2. Morphometric data in type I MCGN and normal humans
Mean Mesangial
glomerular volume!
volume glom.
Vv
(mesangium!
glom.)
Vv
(mes.
cell!
glom.)
Vv (mes.
matrix!
glom.)
PGBM % of
endothelial
circumference
PGBM surface
area/glom.Xj
Sv Vv
(PGBM/ (interstitium!
glom.) cortex) GBMwidth
nmCase no. x106 .un3 3/3 im34un3
1
2
3
4
5
6
7
8
9
2.9 1.6
2.3 1.3
3.6 1.9
2.4 0.9
4.7 2.0
2.1 0.7
2.4 0.6
2.1 0.7
4.0 1.6
0.56
0.56
0.53
0.39
0.42
0.36
0.24
0.33
0.41
0.33
0.36
0,34
0.26
0.27
0.23
0.17
0.23
0.26
0.23
0.20
0.19
0.13
0.15
0.13
0.07
0.11
0.15
30.0
18.4
14.7
34.2
13.5
36.8
50.3
51.5
35.4
34.6
16.2
17.9
96.8
56.0
94.8
216.3
147.7
115.4
0.01 0.48
0.01 0.33
0.01 0.25
0.04 0.22
0.01 0.21
0.05 0.13
0.09 0.11
0.07 0.18
0.03 0.17
338
241
320
293
377
271
308
332
449
Mean
SD
CV
Normal values
Mean
SD
CV
P
2.9 1.3
0.92 0.54
0.31 0.43
1.0 0.2
0.12 0.05
0.12 0.20
<0.001 <0.01
0.42
0.11
0.26
0.22
0.05
0.21
<0.01
0.27
0.06
0.23
0.12
0.03
0.22
<0.001
0.15
0.05
0.33
0.08
0.03
0.34
<0.02
31.6
14.1
0.44
62.4
3.4
0.05
<0.001
88.4
66.0
0.75
110
19
0.17
NS
0.03 0.23
0.03 0.11
0.86 0.49
0.12 0.13
0.02 0.03
0.19 0.26
<0.001 NS
325
61
0.19
342
60
0.18
NS
Abbreviations are: mes, mesangial; gb m., glomerulu5; PGBM, peripheral gIomerular basement membrane.
Volume density of the cortical interstitium [Vv(int/cortex)]
was determined on the light microscopic sections at an approx-
imate magnification of x 170 by point counting images projected
onto a white surface with a projection microscope. Fine points
were counted to determine the number of points falling on the
interstitium (P1) defined as points falling other than on glomer-
uli, tubules and vessels larger than capillaries, whereas coarse
points were counted to determine points falling on the renal
cortex Since each coarse point defined four fine points,
then
P1
Vy(interstitiumjconex) =
Prc X
(jsm3jsm3)
Mean glomerular basement membrane (GBM) width was
determined using the orthogonal intercept method [8, 17, 18].
Statistics
Relationships between renal structural and functional values
were examined by regression analyses (method of least
squares). Comparisons of group data were performed by the
two-tailed Student's t-test. Results are expressed as mean
standard deviation. Values of P < 0.05 were considered to be
statistically significant.
Results
Patient characteristics
Renal function among the nine MCGN type I patients varied
widely. Cr ranged from 10 to 129 mI/minll .73 m2, urinary
protein excretion (UPE) from 0.15 to 3.37 g/day/m2 and UPE/mI
Ccr from 2 to 423 rg/ml (Table 1). Three patients were
hypertensive; all three had CCr less than 80 ml/min/l.73 m2.
Structural-functional relationships were performed on baseline
biopsies prior to the institution of anti-inflammatory treatment.
Followed for 3 to 64 months, four patients have improved, four
are stable and one with Cr of 10 at the time of study has
required renal transplantation. Earlier, patients were treated
with daily prednisone and azathioprine. More recently, alter-
nate day prednisone has been used. Given the small number of
patients, the multiplicity of treatment schedules and the wide
clinical range among the patients at baseline, no conclusions
regarding the effectiveness of these therapies could be derived
from the current study.
Structure in type I MCGN versuscontrols
Mean glomerular volume (GV) was markedly increased in all
patients, being 2 to 4.5 times the mean GV for the control
subjects (Table 2). Whereas GV in the MCGN type I group
averaged about three times that of the normals, mesangial
volume per glomerulus was more than five times that of the
normals. This reflected in an approximate doubling of the
Vv(mes/glom) in the patients (Table 2). Vv(mes cell/glom) was
greater in the MCGN patients than in the controls (P < 0.001)
and Vv(mes matrix/glom) was also increased (P < 0.02; Table
2). In fact, on average about 2/3 of the increase in Vv(mes!glom)
was due to increased Vv(mes celL/glom), and 1/3 due to in-
creased Vv(mes matrix/glom).
The PGBM % of the endothelial circumference was de-
creased in the Type I MCGN patients. However, because of
glomerular enlargement PGBM surface area per glomerulus was
not significantly reduced in the patients compared to the con-
trols (Table 2). Vv(int/cortex) varied widely among the patients
and was not significantly different from controls where wide
variations were also seen. There was no significant difference in
GBM width.
Structural-functional correlations in type I MCGN
Vv(mes/glom) correlated inversely with C. (r = —0.87; P <
0.01; Fig. 1) and PGBM surface per glomerulus correlated
directly with Cr (r = +0.83; P <0.01; Fig. 2). In addition, C.
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m
Fig. 1. Relationship between Vv(mesangium/glom) and creatinine
clearance (r =
—0.87, P < 0.01).
B
B
Fig. 2. Relationship between PGBM surface area per glomerulus and
creatinine clearance (r = +0.83, P <0.01).
0 20 40 60 80 100 120 140 160
Creatinine clearance
mI/mm/i. 73 in2
Fig. 3. Relationship between Vv(interstitium/cortex) and creatinine
clearance. Note log scale for Vv(interstitium/cortex). (r =
—0.87, P <
0.01)
0 100 200 300
alterations with the functional consequences of the disease.
Confirming other studies [4, 5], patients with type I MCGN had
a marked increase in glomerular volume to three times the mean
glomerular volume as well as a near doubling of volume density
of mesangium per glomerulus. Thus, on average, the absolute
volume of the mesangium per glomerulus was increased more
than sixfold. This was mainly due to increased mesangial cell
volume whereas expansion of mesangial matrix was less impor-
tant. This is opposite to what occurs in diabetic nephropathy
where mesangial expansion is due to increased mesangial
matrix [19]. Finally, compared to normal glomeruli, the per-
centage of the glomerular capillary lumenal endothelial circum-
ference which is peripheral GBM, was diminished in type I
B
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Fig. 4. Relationship between mesangial volume per glomerulus and
PGBM surface area per glomerulus (r = —0.73, P < 0.05).
f
B
and log Vv(int/cortex) were inversely correlated (r = —0.87; P
<0.01; Fig. 3). There was no significant relationship between
Ccr and mesangial volume per glomerulus (r = —0.49, NS) or
GBM width (r = +0.41, NS).
There was an inverse relationship between mesangial volume
per glomentlus and PGBM surface area per glomerulus (r =
—0.73; P < 0.05; Fig. 4). There were significant relationships
between Vv(int/cortex) and Vv(mes/glom) (r = +0.91; P <
0.01; Fig. 5) and SV(PGBM/gIom) (r = —0.76; P <0.05; Fig. 6).
Discussion
This is the first study providing detailed data regarding
glomerular structural alterations and structural-functional rela-
tionships in Type I MCGN. These studies are important in that
they provide strong evidence linking glomerular structural
MCGN patients. This decrease was probably consequent to
mesangial expansion [8] as well as to mesangial interposition.
Creatinine clearance in type I MCGN patients was highly
correlated, inversely with Vv(mes/glom) and directly with
PGBM surface area per glomerulus. Creatinine clearance was,
as has previously been reported [6, 7], also correlated with the
extent of the interstitial changes [6, 71. Thus, in type I MCGN
biopsies there are correlations between GFR and both the
glomerular lesions and cortical interstitial lesions. These cor-
relative findings cannot be given direct causal interpretations
and it is not possible to conclude with certainty whether it is the
glomerular or the interstitial lesions or both which are the
crucial renal functional determinants in type I MCGN. How-
phenomenon. Also, it should be recognized that measurements
of cortical interstitial volume fraction are relatively crude and
do not per se indicate whether the changes represent abnormal-
ities in interstitial matrix, alterations in interrelationships be-
tween matrix, peritubular capillaries and interstitial lymphatic
structures [231, changes in interstitial cell number or type or
abnormalities in interstitial water content. Changes in each of
these interstitial components may well have different functional
consequences. It would therefore be of great interest to study
pure interstitial renal injury to determine whether interstitial
alterations of the magnitude associated with those seen in
glomerular disorders such as diabetes or MCGN are, by them-
selves, associated with similar degrees of renal dysfunction.
In summary, renal functional disturbances are linked to
mesangial expansion and especially to mesangial cellular expan-
sion in MCGN type I. Efforts to understand the pathogenesis of
this expansion might lead to new treatment options for this
important form of chronic glomerular injury.
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U ever, it can no longer be accepted that one cannot predict
glomerular function from examining glomerular structure in
primary glomerular disorders. Morphometric analyses in dia-
0.4 betic nephropathy [8, 13], membranous nephropathy [20] and
now MCGN type I indicate that, carefully quantitated, glomer-
ular structure is at least as informative as interstitial structure in
U predicting renal filtration function.
0.3 In each of these three glomerular disorders important direct
correlations have emerged between measures of glomerular
u filtration surface and GFR, providing a ready explanation for
the GFR alterations observed. On the other hand the mecha-> 02 El nism whereby increased cortical interstitial volume may be
El influencing GFR is less clear. A significant inverse correlation
U has been reported between crude measures of kidney function
0 1 ________________________________________ (serum creatinine) and an estimate of interstitial capillary nu-
0 2 0 3 0 0 0 07 merical density in patients with a variety of glomerulopathies[21]. However, it is not possible to determine from these studies
Vv (mesangium/glom) whether the changes in interstitial capillaries are related to
um34um3 interstitial pathology or represent downstream alterations con-
sequent to decreased glomerular capillary circulation. Since in
Fig. 5. Relationship between Vv(interstitium/cortex) and Vv(me- both diabetes [8, 22] and MCGN type I, the volume fraction of
sangium/glom) (r = +0.91, P < 0.01). . . .cortex which is interstitium and the seventy of glomerular
lesions are highly directly correlated, it is possible that the
interstitial changes in these disorders represent a secondary
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Fig. 6. Relationship between Vv(interstitium/cortex) and Sv(PGBM/
gloin). Note log scale for Vv(interstitium/cortex) (r —0.76, P < 0.05).
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